Skip to main content

Table 4 Multivariate analysis of variables with p < 0.05 and significant HR as univariate for overall and progression free survival (N = 158). 95% confidence levels are indicated in the parentheses for the Hazard Ratios (HR)

From: Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer

Factor

HR OS

P OS

HR PFS

P PFS

Age (>  58)

5.3 (1.7–17.0)

0.005

3.2 (1.3–7.8)

0.01

ColXα1

2.1 (1.2–3.9)

0.01

1.8 (1.6–5.7)

0.01

Clinical Stage

2.6 (1.3–5.2)

0.008

2.7 (1.6–4.7)

< 0.001